Results 111 to 120 of about 486,907 (280)

Safety and Feasibility of Infusing Ex Vivo Expanded Allogeneic Canine Natural Killer Cells for the Treatment of Metastatic Solid Tumours

open access: yesVeterinary and Comparative Oncology, EarlyView.
ABSTRACT Companion canines need advances in therapeutic options for solid tumour malignancies. Natural killer (NK) cell infusions offer a promising treatment modality in canines with solid tumours. Autologous natural killer products are limited by dysfunctional immunity and a manufacturing process that delays care whereas allogeneic NK cells offer the ...
Allison M. Weisnicht   +11 more
wiley   +1 more source

Medical Thoracoscopy in the Management of Malignant Pleural Effusion

open access: yes, 2013
Malignant pleural effusion is one of the most common problems that chest physicians face in their everyday practice. The diagnosis of malignant pleural effusion requires either a histological or cytological demonstration of malignant cells in the pleural
YILDIRIM, HÜSEYİN
core   +1 more source

Early Gastric Cancer Detected During 15‐year Surveillance After Ménétrier Disease Remission and Successfully Treated With Endoscopic Submucosal Dissection: A Case Report

open access: yesDEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Ménétrier disease (MD) was diagnosed based on hypoalbuminemia and giant gastric folds extending from the body to the fundus in a woman in her 70s. A serum anti‐Helicobacter pylori antibody test and urea breath test yielded negative results.
Takaaki Shamoto   +8 more
wiley   +1 more source

Nanobiomechanics in Oncology: Atomic Force Microscopy for Cancer Mechanophenotyping Using Cellular Young's Modulus

open access: yesJournal of the Royal Society of New Zealand, Volume 57, Issue 1, February 2027.
This review examines the current literature on the application of atomic force microscopy (AFM) to cancer mechanophenotyping, with particular emphasis on cellular Young's modulus and its potential diagnostic significance. A structured electronic search of PubMed, Scopus and Google Scholar was conducted to identify studies published between 1999 and ...
Hermawan Tjoa   +4 more
wiley   +1 more source

Severe Adverse Reactions Induced by the Chest Injection of Elemene: 
An Analysis of 7 Cases

open access: yesChinese Journal of Lung Cancer, 2018
Background and objective Malignant pleural effusion (MPE) refers to pleural effusion which arises from primary malignant tumor of pleura or other pleural metastatic tumors.
Fei GAO   +4 more
doaj   +1 more source

Ewing Sarcoma in Infants and Children Under 2 Years of Age: A French Retrospective Study

open access: yesPediatric Blood &Cancer, Volume 73, Issue 11, November 2026.
ABSTRACT Ewing sarcoma, the second most common primary bone cancer in children, requires intensive treatment that may lead to significant long‐term sequelae, particularly in infants. We retrospectively analyzed data from 1621 French patients treated between 1988 and 2015 within the EW88/93/97 or EE99 trials, focusing on 17 infants diagnosed before 24 ...
Elodie Verdier   +18 more
wiley   +1 more source

Clinical role of PET/CT in distinguishing malignant from benign pleural effusion in non-small cell lung cancer 

open access: yes肿瘤影像学, 2019
Objective: To explore the clinical role of  18 F-FDG PET/CT in distinguishing malignant from benign pleural effusion in pretreatment non-small cell lung cancer (NSCLC) patients.
ZHANG Weishan   +4 more
doaj  

Stage IV Ovarian Cancer Is Not Uniformly Lethal: Two Subgroups With Stage II‐Like Outcomes Identified in Large Retrospective Cohorts

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Background The International Federation of Gynecology and Obstetrics (FIGO) staging system for advanced ovarian cancer has remained largely static since 2014, with stage IV subdivided into IVA and IVB without further stratification. Emerging evidence suggests substantial prognostic heterogeneity within stage IV, yet large‐scale validation ...
Cheng Fang, Jundong Li, Qiaqia Li
wiley   +1 more source

Surgical Removal of Residual Tumor Masses in Patients Undergoing Targeted Therapy for EGFR‐Mutated Locally Advanced or Metastatic Lung Cancer

open access: yesInternational Journal of Cancer, Volume 159, Issue 9, Page 2244-2261, 1 November 2026.
Non‐small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations often exhibit significant tumor reduction following tyrosine kinase inhibitor (TKI) therapy. Residual tumors frequently remain, however, leading to drug resistance and disease progression.
Fedor Moiseenko   +31 more
wiley   +1 more source

Comparison of measurements in spectral CT between benign and malignant pleural effusion.

open access: yes, 2018
Comparison of measurements in spectral CT between benign and malignant pleural effusion.
Yuxin Lei (5088806)   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy